The Argentine authorities consider the results of the use of the Russian vaccine against the Sputnik V coronavirus encouraging. such an assessment was given by the assistant to the president of the country, Cecilia Nicolini, RIA Novosti reported.
According to Nicolini, the results of the Sputnik V vaccination are encouraging not only in terms of safety and efficacy, but also in terms of minor side effects. At the same time, she noted that Argentina is interested in access to other Russian vaccines against the coronavirus EpiVacCorona and CoviVac. Nicolini explained that in Argentina they trust Russian science and technological development and are confident that these drugs will be of the same quality.
Nicolini added that Argentina plans to start production of Sputnik V in 12-18 months, the exact time should be determined by the laboratory together with experts and specialists. In addition, it takes time to set up a plant, transfer technology, supply equipment and find employees.
Argentine authorities registered the Russian Sputnik V coronavirus vaccine on December 23. Prior to this, the country's government signed an agreement for the supply of ten million doses of the Russian drug. Argentine President Alberto Fernandez received the vaccine on January 21. On December 24, the country received the first batch of the drug in the amount of 300 thousand doses.
Sputnik V was developed by the Russian Gamaleya Research Center for Electrochemistry and became the world's first officially registered vaccine against coronavirus. It was created on the basis of another adenovirus in which the coronavirus gene is embedded. When it enters the cells, it forms proteins in them – they cause an immune response and promote the development of antibodies.
